{
  "id": "mhgap#screening_cues_02540dfa",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "EPI 3 Follow-up RECOMMENDATIONS ON FREQUENCY OF CONTACT 1 » Follow up should occur every 3-6 months REVIEW THE CURRENT CONDITION Does the person have more than 50% seizure reduction in convulsion frequency? IF THE PERSON IS NOT IMPROVING ON CURRENT DOSE: » Review adherence to medications. » Consider increase in medication dose as needed to maximal dose if no adverse effects. » If response is still poor, – Consider switching medication. The new medication should be at an optimum dose before slowly discon- tinuing the first. » If response is still poor, – Review diagnosis. – REFER TO SPECIALIST. » Follow-up more frequently. CLINICAL TIP: » ADVERSE EFFECTS (e.g. drowsiness, nystagmus, diplopia, ataxia) are from too high doses of medication for the person. » If there is an IDIOSYNCRATIC REACTION (allergic reaction, bone marrow depression, hepatic failure), switch antiepileptic medication. EPILEPSY 67 68 EPI 3 EPILEPSY Follow-up 2 MONITOR TREATMENT At every contact: » » Evaluate side-effects of medication including adverse effects Does the patient have any new symptoms of concern? and idiosyncratic reactions (clinically and with appropriate laboratory tests Review",
  "gloss_vi": "Epi 3 follow-up recommendations on frequency of contact 1 » follow up should occur every 3-6 months review the current condition does the person have more than 50% seizure reduction in convulsion frequency? if the person...",
  "source": "WHO mhGAP-IG 2023",
  "url": "https://www.who.int/",
  "lang": "en",
  "axes": {
    "type": [
      "clinical"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues",
      "referral",
      "management"
    ],
    "life_topics": [],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc EPI 3 Follow-up RECOMMENDATIONS ON FREQUENCY OF CONTACT 1 » Follow up should occur every 3-6 months REVIEW THE CURRENT CONDITION Does the person have more than 50% seizure reduction in convulsion frequency? IF THE PERSON IS NOT IMPROVING ON CURRENT DOSE: » Review adherence to medications. » Consider increase in medication dose as needed to maximal dose if no adverse effects. » If response is still poor, – Consider switching medication. The new medication should be at an optimum dose before slowly discon- tinuing the first. » If response is still poor, – Review diagnosis. – REFER TO SPECIALIST. » Follow-up more frequently. CLINICAL TIP: » ADVERSE EFFECTS (e.g. drowsiness, nystagmus, diplopia, ataxia) are from too high doses of medication for the person. » If there is an IDIOSYNCRATIC REACTION (allergic reaction, bone marrow depression, hepatic failure), switch antiepileptic medication. EPILEPSY 67 68 EPI 3 EPILEPSY Follow-up 2 MONITOR TREATMENT At every contact: » » Evaluate side-effects of medication including adverse effects Does the patient have any new symptoms of concern? and idiosyncratic reactions (clinically and with appropriate laboratory tests Review Epi 3 follow-up recommendations on frequency of contact 1 » follow up should occur every 3-6 months review the current condition does the person have more than 50% seizure reduction in convulsion frequency? if the person..."
}